The value of Platelet-Rich Plasma injections in the treatment of the jumper's knee: a double-blind randomised trial
Phase 3
Completed
- Conditions
- jumper's knee and apexitis10043237
- Registration Number
- NL-OMON37132
- Lead Sponsor
- Meander Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
- pain at the inferior pole of the patella for 3 months
- age 18-55 year
- tendinosis or thickening compared with the contralateral side of > 3 mm, detected with ultrasonography or MRI
- already undergone eccentric training for 6 weeks following a standardised protocol
Exclusion Criteria
- pregnancy
- injection in the patellar tendon in the last 3 months, irrespective of the applied substance
- operations on the patellar tendon in the past
- calcifications in the proximal patellar tendon
- at examination indications for intraarticular pathology or patellofemoral pain syndrome
- chronic NSAID use in the past 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary outcome measure will be VISA-P score. This is a valid scoring system to<br /><br>assess jumper's knee, 100 points maximum, meaning normal functioning knee and 0<br /><br>points minimum.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcome measures will be VAS score, return to sports (extent and<br /><br>level), degree of ultrasound pathology and costs.</p><br>